![CEA clearance pattern as a predictor of tumor response to neoadjuvant treatment in rectal cancer: a post-hoc analysis of FOWARC trial | BMC Cancer | Full Text CEA clearance pattern as a predictor of tumor response to neoadjuvant treatment in rectal cancer: a post-hoc analysis of FOWARC trial | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-018-4997-y/MediaObjects/12885_2018_4997_Fig1_HTML.png)
CEA clearance pattern as a predictor of tumor response to neoadjuvant treatment in rectal cancer: a post-hoc analysis of FOWARC trial | BMC Cancer | Full Text
![A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel | Scientific Reports A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-80785-1/MediaObjects/41598_2020_80785_Fig1_HTML.png)
A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel | Scientific Reports
![False-Positive Elevations of Carcinoembryonic Antigen in Patients With a History of Resected Colorectal Cancer in: Journal of the National Comprehensive Cancer Network Volume 12 Issue 6 (2014) False-Positive Elevations of Carcinoembryonic Antigen in Patients With a History of Resected Colorectal Cancer in: Journal of the National Comprehensive Cancer Network Volume 12 Issue 6 (2014)](https://jnccn.org/view/journals/jnccn/12/6/0907tbl01.jpeg)
False-Positive Elevations of Carcinoembryonic Antigen in Patients With a History of Resected Colorectal Cancer in: Journal of the National Comprehensive Cancer Network Volume 12 Issue 6 (2014)
The diagnostic accuracy of a single CEA blood test in detecting colorectal cancer recurrence: Results from the FACS trial | PLOS ONE
The effect of visceral fat on the hemodilution effect of serum carcinoembryonic antigen in Korean population | PLOS ONE
![No benefit of more intense follow-up after surgery for colorectal cancer in the risk group with elevated CEA levels – An analysis within the COLOFOL randomized clinical trial - ScienceDirect No benefit of more intense follow-up after surgery for colorectal cancer in the risk group with elevated CEA levels – An analysis within the COLOFOL randomized clinical trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0748798321003772-gr1.jpg)
No benefit of more intense follow-up after surgery for colorectal cancer in the risk group with elevated CEA levels – An analysis within the COLOFOL randomized clinical trial - ScienceDirect
![Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0960977620301120-gr2.jpg)
Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect
![SciELO - Brasil - Determination of carcinoembryonic antigen levels in peripheral and draining venous blood in patients with colorectal carcinoma Determination of carcinoembryonic antigen levels in peripheral and draining venous blood in SciELO - Brasil - Determination of carcinoembryonic antigen levels in peripheral and draining venous blood in patients with colorectal carcinoma Determination of carcinoembryonic antigen levels in peripheral and draining venous blood in](https://minio.scielo.br/documentstore/1678-4219/6jhVqgyLkhLRqk4rY7q7zhc/174f0b965a4a324237d6e4ec4620c46ee48f2962.gif)